Jesús Costa-Tort1, Verónica Schiavo-Di Flaviano2, Beatriz González-Navarro3, Enric Jané-Salas4, Albert Estrugo-Devesa4, José López-López5. 1. DDS, Master's student. School of Dentistry, University of Barcelona. University Campus of Bellvitge, Barcelona, Spain. 2. DDS, Master's degree. School of Dentistry, University of Barcelona. University Campus of Bellvitge, Barcelona, Spain. 3. DDS, Professor of Master's degree. School of Dentistry, University of Barcelona. University Campus of Bellvitge, Barcelona, Spain. 4. PhD, DDS, MD. Professor of Oral Pathology. Department of Odontostomatology. Faculty of Medicine and Health Sciences (Dentistry), University of Barcelona. University Campus of Bellvitge, Barcelona, Spain / Oral Health and Masticatory System Group (Bellvitge Biomedical Research Institute) IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain. 5. DDS, MD, PhD, Department of Odontoestomatology. Faculty of Medicine and Health Sciences (School of Dentistry), University of Barcelona. University Campus of Bellvitge, Barcelona, Spain. / Dental Hospital University of Barcelona, (Barcelona University) / Oral Health and Masticatory System Group (Bellvitge Biomedical Research Institute) IDIBELL, Barcelona, Spain.
Abstract
BACKGROUND: Oral antiplatelet and anticoagulant drugs are widely used in a large number of patients visiting the dentist, and there has been much controversy over the years towards their clinical management. The aim to carry out a literature review in order to develop an update on dental management in anticoagulated and / or anti aggregated patients, focusing on oral surgery. MATERIAL AND METHODS: A bibliographic search was carried out in PubMed on studies published between January 1, 2018, until December 10, 2020, using the keywords ("antiplatelet" OR "antiplatelets") AND ("dentistry"), and ("anticoagulant" OR "anticoagulants") AND ("dentistry"). RESULTS: The number of studies included in this review was 13, and the number of patients among all of them was 3.497 patients under treatment with some type of antithrombotic drug, who underwent different oral surgery treatments. CONCLUSIONS: There is a low risk of peri- and postoperative bleeding events during basic oral surgery treatments in antiplatelet or anticoagulated patients, which can be easily managed through the use of local haemostatic measures. Key words:Oral surgery, antiplatelet drugs, anticoagulant drugs, dental treatment. Copyright:
BACKGROUND: Oral antiplatelet and anticoagulant drugs are widely used in a large number of patients visiting the dentist, and there has been much controversy over the years towards their clinical management. The aim to carry out a literature review in order to develop an update on dental management in anticoagulated and / or anti aggregated patients, focusing on oral surgery. MATERIAL AND METHODS: A bibliographic search was carried out in PubMed on studies published between January 1, 2018, until December 10, 2020, using the keywords ("antiplatelet" OR "antiplatelets") AND ("dentistry"), and ("anticoagulant" OR "anticoagulants") AND ("dentistry"). RESULTS: The number of studies included in this review was 13, and the number of patients among all of them was 3.497 patients under treatment with some type of antithrombotic drug, who underwent different oral surgery treatments. CONCLUSIONS: There is a low risk of peri- and postoperative bleeding events during basic oral surgery treatments in antiplatelet or anticoagulated patients, which can be easily managed through the use of local haemostatic measures. Key words:Oral surgery, antiplatelet drugs, anticoagulant drugs, dental treatment. Copyright:
Authors: Ryan T Rubino; Dolph R Dawson; Richard J Kryscio; Mohanad Al-Sabbagh; Craig S Miller Journal: Oral Surg Oral Med Oral Pathol Oral Radiol Date: 2019-04-16
Authors: Amanda L Rocha; Alessandra F Souza; Maria A P Martins; Marina G Fraga; Denise V Travassos; Ana C B Oliveira; Daniel D Ribeiro; Tarcília A Silva Journal: Blood Coagul Fibrinolysis Date: 2018-01 Impact factor: 1.276
Authors: Martin Müller; Fabian Schlittler; Benoit Schaller; Michael Nagler; Aristomenis K Exadaktylos; Thomas C Sauter Journal: Clin Oral Investig Date: 2018-10-05 Impact factor: 3.573